ARPA–H Act

Advanced Research Projects Agency - Health Act (H.R.5585) American Rescue Plan Act (H.R. 1319): access to care, nutrition security, public health infrastructure. Build Back Better Act (H.R. 5376): access to care, nutrition security, medical research, public health infrastructure, tobacco tax, maternal health, paid family and medical leave. The Cardiovascular Advances in Research and Opportunities Legacy Act - the CAROL Act (H.R. 1193/ S. 1133) Consolidated Appropriations Act, 2022 (Pub.L. 117-103) The PHIT Act (S. 844/H.R. 1679) FY 2023 Labor-HHS-Education Appropriations (no bill number): NIH, CDC, AHRQ funding and report language; Department of Ed Title IV funding; funding for the Title V Maternal and Child Health Block Grant FY 2023 Agriculture-FDA Appropriations (no bill number): nutrition policy, FDA funding, and tobacco report language FY 2023 Military Construction-VA Appropriations (no bill number): VA medical and prosthetic research funding FY 2023 State and foreign Operations Appropriations (no bill number): global health

Client expense: $110,000 · Firm income: Not reported

Government targets: Agency for Healthcare Research & Quality (AHRQ), Agriculture, Dept of (USDA), Centers For Disease Control & Prevention (CDC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE, Veterans Affairs, Dept of (VA), White House Office

Expressed support for the use of Animal Research in National Institutes of Health Grants Discussed lab-developed test regulations Expressed support for the 340b program Expressed support for PREVENTS Pandemic Act (S.3397) Support the passage of the ARPA-H Act (S. 3819, H.R. 5585) Support the passage of CURES 2.0 (H.R. 6000)

Client expense: $132,536 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 4346 - CHIPS and Science Act of 2022 H.R. 5585 - Advanced Research Project Agency-Health (ARPA-H) Act H.R. 5874 - Restoring Americas Leadership in Innovation Act of 2021 H.R. 7900 - National Defense Authorization Act for FY23 (NDAA) H.R. 6588 - Cyber Ready Workforce Act H.R. 7152 - Tracking Pathogens Act H.R. 7289 - Federal PFAS Research Evaluation Act H.R. 7430 - Protecting American Innovation Act H.R. 8152 - American Data Privacy and Protection Act (ADPPA) S. 1351 - Safeguarding American Innovation Act S. 4543 - James M. Inhofe National Defense Authorization Act for Fiscal Year 2023 (NDAA) S. 4756 - Preventing Malign Chinese Influence on Academic Institutions S. 4900 - SBIR and STTR Extension Act of 2022 -- regarding research-related funding and policy issues affecting higher education institutions and their faculty and students.

Client expense: $50,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Office of Science & Technology Policy (OSTP), SENATE

H.R. 2256, Resident Physician Shortage Reduction Act of 2021 H.R. 2617, Consolidated Appropriations Act, 2023 (P.L. 117-328); Medicaid shortfall definition related issues; extension of Medicaid Federal Medical Assistance Percentage (FMAP) increase; extension of telehealth waivers; extension of the CMS Acute Hospital Care at Home wavier; funding for the National Institutes of Health (NIH); funding for the Advanced Research Projects Agency for Health (ARPA-H); Graduate Medical Education (GME) funding issues; funding for telehealth programs; health workforce programs; issues related to the CMS Physician Fee Schedule; H.R. 4040, Advancing Telehealth Beyond COVID-19 Act of 2021 H.R. 5585, ARPA-H Act H.R. 7053, Hospital Inpatient Services Modernization Act

Client expense: $320,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Drug pricing issues; CMS reimbursement including Medicare coverage of innovative technology; Ensuring Patient Access to Critical Breakthrough Products Act H.R.4043; Inflation Reduction Act (HR 5376) Public Law No. 117-169.; Cures 2.0 Act H.R.6000; Proposals for Advanced Research Project Agency- Health: ARPA-H Act, H.R.5585.

Client expense: $790,191 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office

H.R. 623: Gabriella Miller Kids First Research Act 2.0 H.R. 724: Reciprocity Ensures Streamlined Use of Lifesaving Treatments Act of 2021 - Provisions related to FDA drug approval process H.R. 832: Safe and Affordable Drugs from Canada Act of 2021 - Provisions related to prescription drug importation H.R. 1400: COVID-19 Health Disparities Action Act of 2021 - Provisions related to COVID-19 vaccines H.R. 1730: Speeding Therapy Access Today Act of 2021 - Provisions related to FDA policy and health research H.R. 1873: Advancing Education on Biosimilars Act of 2021 - Provisions related to biologics and biosimilar products HR 1978 - Protecting Seniors Through Immunization Act H.R. 2181: Affordable and Safe Prescription Drug Importation Act - Provisions related to prescription drug importation H.R. 2565: FDA Modernization Act of 2021 - Provisions related to FDA policy and health research H.R. 2831: Prompt Approval of Safe Generic Drugs Act- Provisions related to FDA policy and approvals H.R. 2843: STOP GAMES Act of 2021 - Provisions related to citizen petitions H.R. 3761: Promising Pathways Act - Provisions related to FDA policy H.R. 3932: PASTEUR Act of 2021 - Provisions related to antimicrobial resistance policy issues H.R. 4390: PROTECT 340B Act of 2021 - Provisions related to 340B drug discount program H.R. 4472: BENEFIT Act of 2021 - Provisions related to FDA policy H.R. 4511: FDA Advancing Collection of Transformative Science Act or the FACTS Act  H.R. 5030: DIVERSE Trials Act- Diversifying Investigations Via Equitable Research Studies for Everyone H.R. 5376: Inflation Reduction Act of 2022 (P.L. 117-169) H.R. 5416: Give Kids a Chance Act H.R. 5585: Advanced Research Project Agency-Health Act - Provisions related to health research H.R. 5801: HELP Copays Act - Provisions related to prescription drug pricing and cost-sharing, patient assistance H.R. 6000: Cures 2.0 Act - Provisions related to health research H.R. 6584: DEPICT Act - To direct the Commissioner of Food and Drugs to amend certain regulations to increase clinical trial diversity, and for other purposes H.R. 6833: Continuing Appropriations and Ukraine Supplemental Appropriations Act, 2023 - User fee reauthorization (P.L. 117-180); PDUFA provisions related to intellectual property H.R. 6963: Accelerated Approval Integrity Act of 2022 - Provisions related to accelerated approval H.R. 6972: Give Kids a Chance Act of 2022 - Provisions related to additional authorities and pediatric investigations H.R. 6973: Enhanced Access to Affordable Medicines Act of 2022 - Provisions related to labeling H.R. 7008: Pre-Approval Information Exchange Act of 2022   H.R. 7047: Lowering Costs by Improving Biosimilar Uptake Act H.R. 7667: Food and Drug Amendments Act of 2022 - To amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user-fee programs for prescription drugs, medical devices, generic drugs, and biosimilar biological products, and for other purposes H.R. 7845: NIH Clinical Trial Diversity Act of 2022 H.R. 7900: National Defense Authorization Act for Fiscal Year 2023 H.R. 8152: American Data Privacy and Protection Act S. 154: Reciprocity Ensures Streamlined Use of Lifesaving Treatments Act of 2021- Provisions related to FDA drug approval process S. 164: Advancing Education on Biosimilars Act of 2021 - Provisions related to biologics and biosimilar products S. 259: Safe and Affordable Drugs from Canada Act of 2021 - Provisions related to prescription drug importation S. 562: Ensuring Timely Access to Generics Act of 2021 - Provisions related to citizen petitions S. 773: A bill to enable certain hospitals that were participating in or applied for the drug discount program under section 340B of the Public Health Service Act prior to the COVID-19 public health emergency to temporarily maintain eligibility for such program, and for other purposes - Provisions related to 340B drug discount program S. 920: Affordable and Safe Prescription Drug Importation Act - Provisions related to prescription drug importation S. 1425: Stop STALLING Act - Provisions related to citizen petitions S. 1462: Simplifying the Generic Drug Application Process Act - Provisions related to FDA policy and approvals S. 1644: Promising Pathway Act - Provisions related to FDA policy S. 1645: ADAPT Act - Provisions related to FDA policy S. 2076: PASTEUR Act of 2021 - Provisions related to antimicrobial resistance policy issues S. 2706: DIVERSE Trials Act - Provisions related to FDA policy S. 2837: 340B Accountability Act of 2021 - Provisions related to 340B drug discount program S. 2983: ADAPT for COVID Act - Provisions related to FDA accelerated approval pathways S. 3799: Prepare for and Respond to Existing Viruses, Emerging New Threats, and Pandemics Act or PREVENT Pandemics Act S. 4215: Give Kids a Chance Act of 2022 S. 4348: FDASLA Act of 2022 - To amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user-fee programs for prescription drugs, medical devices, generic drugs, and biosimilar biological products, and for other purposes S. 4430: Interagency Patent Coordination and Improvement Act of 2022 S. 4535: Food and Drug Administration Simple Reauthorization Act of 2022 S. 4918: Increasing Prescription Drug Competition Act - Patent-related policy issues Cancer Moonshot Initiative 21st Century Cures 2.0 Department of Homeland Security cybersecurity policy issues Drug cost and pricing policy issues Principles for drug pricing reform Drug importation policy issues Drug counterfeiting policy issues Direct to consumer advertising policy issues Competition policy issues Orphan Drug Act policy issues Expanded access policy issues Antimicrobial resistance (AMR) policy issues Mental health policy issues High deductible health plans/HSA policy issues Supply chain and foreign manufacturing policy issues Real world evidence policy issues Clinical trial diversity policy issues Prescription drug abuse and fentanyl policy issues 340B drug discount program policy issues Patient assistance program policy issues Biosimilar approval and reimbursement policy issues Drug shortages policy issues COVID-19 policy issues Pandemic preparedness policy issues Issues related to HFC's Defense Production Act (DPA) policy issues Final Rule; Importation of Prescription Drugs Buy America and other associated issues related to procurement and sourcing of finished product and active pharmaceutical ingredients Notice of Proposed Rulemaking; 340B Drug Pricing Program; Administrative Dispute Resolution; 87 Fed. Reg. 73516 (Nov. 30, 2022) Veterans' Affairs issues related to product sampling Provisions related to the importation of HFCs, necessary for MDI production. P.L.116-260 - AIM Act - EPA Propellant Allowances for metered dose inhaler manufacturing PDUFA riders legislation (Accelerated Approval, Clinical Trial Diversity, Q1Q2)

Client expense: $860,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE

H.R. 6000, Cures 2.0 Issue: Provide feedback on provisions related to research and ARPA-H. Support inclusion of RISE Act. H.R. 5585, ARPA-H Act S.3799, PREVENT Pandemics Act S. 3819, ARPA-H Act P.L. 117-328, Consolidated Appropriations Act, 2023, Division FF Issue: Provide feedback on legislation to establish Advanced Research Project Agency/Authority for Health (ARPA-H). P.L. 117-328, Consolidated Appropriations Act, 2023, Division FF Issue: Support clinical trials diversity. Issue: Support prompt establishment of the Research Policy Board and implementation of the additional reform efforts required by Section 2034 of the 21st Century Cures Act (P.L. 114-255). Issue: Support ethical use of fetal tissue in medical research. Issue: Provide input on criteria for next NIH director.

Client expense: $876,000 · Firm income: Not reported

Government targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Office of Science & Technology Policy (OSTP), SENATE, White House Office

H.R. 5: Equality Act H.R. 623: Gabriella Miller Kids First Research Act 2.0 H.R. 724: Reciprocity Ensures Streamlined Use of Lifesaving Treatments Act of 2021 - Provisions related to FDA drug approval process H.R. 832: Safe and Affordable Drugs from Canada Act of 2021 - Provisions related to prescription drug importation H.R. 1400: COVID-19 Health Disparities Action Act of 2021 - Provisions related to COVID-19 vaccines H.R. 1730: Speeding Therapy Access Today Act of 2021 - Provisions related to FDA policy and health research H.R. 1873: Advancing Education on Biosimilars Act of 2021 - Provisions related to biologics and biosimilar products H.R. 2181: Affordable and Safe Prescription Drug Importation Act - Provisions related to prescription drug importation H.R. 2565: FDA Modernization Act of 2021 - Provisions related to FDA policy and health research H.R. 2831: Prompt Approval of Safe Generic Drugs Act - Provisions related to FDA policy and approvals H.R. 2843: STOP GAMES Act of 2021 - Provisions related to citizen petitions H.R. 3085: ENACT Act of 2021 - Sets out activities and requirements to increase the participation of underrepresented populations in research and clinical trials for Alzheimers disease and related dementias H.R. 3761: Promising Pathways Act - Provisions related to FDA policy H.R. 3932: PASTEUR Act of 2021 - Provisions related to antimicrobial resistance policy issues H.R. 4390: PROTECT 340B Act of 2021 - Provisions related to 340B drug discount program H.R. 4472: BENEFIT Act of 2021 - Provisions related to FDA policy H.R. 4511: FDA Advancing Collection of Transformative Science Act or the FACTS Act H.R. 5030: DIVERSE Trials Act - Diversifying Investigations Via Equitable Research Studies for Everyone H.R. 5376: Inflation Reduction Act of 2022 (P.L. 117-169) H.R. 5416: Give Kids a Chance Act H.R. 5585: Advanced Research Project Agency-Health Act - Provisions related to health research H.R. 5801: HELP Copays Act - Provisions related to prescription drug pricing and cost-sharing H.R. 6000: Cures 2.0 Act - Provisions related to health research H.R. 6584: DEPICT Act - To direct the Commissioner of Food and Drugs to amend certain regulations to increase clinical trial diversity, and for other purposes H.R. 6833: Continuing Appropriations and Ukraine Supplemental Appropriations Act, 2023 - User fee reauthorization (P.L. 117-180) H.R. 6963: Accelerated Approval Integrity Act of 2022 - Provisions related to accelerated approval H.R. 6972: Give Kids a Chance Act of 2022 - Provisions related to additional authorities and pediatric investigations H.R. 6973: Enhanced Access to Affordable Medicines Act of 2022 - Provisions related to labeling H.R. 7008: Pre-Approval Information Exchange Act of 2022   H.R. 7047: Lowering Costs by Improving Biosimilar Uptake Act H.R. 7667: Food and Drug Amendments Act of 2022 - To amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user-fee programs for prescription drugs, medical devices, generic drugs, and biosimilar biological products, and for other purposes H.R. 7845: NIH Clinical Trial Diversity Act of 2022 H.R. 7900: National Defense Authorization Act for Fiscal Year 2023 H.R. 8152: American Data Privacy and Protection Act S. 154: Reciprocity Ensures Streamlined Use of Lifesaving Treatments Act of 2021 - Provisions related to FDA drug approval process S. 164: Advancing Education on Biosimilars Act of 2021 - Provisions related to biologics and biosimilar products S. 259: Safe and Affordable Drugs from Canada Act of 2021 - Provisions related to prescription drug importation S. 562: Ensuring Timely Access to Generics Act of 2021 - Provisions related to citizen petitions S. 773: A bill to enable certain hospitals that were participating in or applied for the drug discount program under section 340B of the Public Health Service Act prior to the COVID-19 public health emergency to temporarily maintain eligibility for such program, and for other purposes - Provisions related to 340B drug discount program S. 920: Affordable and Safe Prescription Drug Importation Act - Provisions related to prescription drug importation S. 1425: Stop STALLING Act - Provisions related to citizen petitions S. 1462: Simplifying the Generic Drug Application Process Act - Provisions related to FDA policy and approvals S. 1548: ENACT Act of 2021 - Sets out activities and requirements to increase the participation of underrepresented populations in research and clinical trials for Alzheimers disease and related dementias S. 1644: Promising Pathway Act - Provisions related to FDA policy S. 1645: ADAPT Act - Provisions related to FDA policy S. 2076: PASTEUR Act of 2021 - Provisions related to antimicrobial resistance policy issues S. 2706: DIVERSE Trials Act - Provisions related to FDA policy S. 2837: 340B Accountability Act of 2021 - Provisions related to 340B drug discount program S. 2983: ADAPT for COVID Act - Provisions related to FDA accelerated approval pathways S. 3799: Prepare for and Respond to Existing Viruses, Emerging New Threats, and Pandemics Act or PREVENT Pandemics Act S. 4215: Give Kids a Chance Act of 2022 S. 4348: FDASLA Act of 2022 - To amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user-fee programs for prescription drugs, medical devices, generic drugs, and biosimilar biological products, and for other purposes S. 4430: Interagency Patent Coordination and Improvement Act of 2022 S. 4535: Food and Drug Administration Simple Reauthorization Act of 2022 S. 4918: Increasing Prescription Drug Competition Act - Patent-related policy issues Cancer Moonshot Initiative 21st Century Cures 2.0 Department of Homeland Security cybersecurity policy issues Drug cost and pricing policy issues Principles for drug pricing reform Drug importation policy issues Drug counterfeiting policy issues Direct to consumer advertising policy issues Competition policy issues Orphan Drug Act policy issues Expanded access policy issues Antimicrobial resistance (AMR) policy issues Mental health policy issues High deductible health plans/HSA policy issues Supply chain and foreign manufacturing policy issues Real world evidence policy issues Clinical trial diversity policy issues Prescription drug abuse policy issues 340B drug discount program policy issues Patient assistance program policy issues Biosimilar approval and reimbursement policy issues Drug shortages policy issues COVID-19 policy issues Pandemic preparedness policy issues Defense Production Act (DPA) policy issues Final Rule; Importation of Prescription Drugs Notice of Proposed Rulemaking; 340B Drug Pricing Program; Administrative Dispute Resolution; 87 Fed. Reg. 73516 (Nov. 30, 2022) Buy America and other associated issues related to procurement and sourcing of finished product and active pharmaceutical ingredients

Client expense: $6,610,000 · Firm income: Not reported

Government targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Office of Management & Budget (OMB), SENATE

H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act H.R. 1676, Jack Reynolds Memorial Medigap Extension Act H.R. 1255/S. 377, The Living Donor Protection Act of 2021 H.R. 2617, Consolidated Appropriations Act, 2023, issues related to health care H.R. 4065, The Chronic Kidney Disease Improvement in Research and Treatment Act H.R. 5376, Build Back Better Act, provisions relating to health care H.R. 5585, Advanced Research Project Agency Health Act H.R. 6000, Cures 2.0 Act S. 1971, Chronic Kidney Disease Improvement in Research and Treatment Act of 2021 Implementation of Executive Order 13879, Advancing American Kidney Health.

Client expense: $310,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

ARPA-H Act (H.R.5585) Food and Drug Amendments Act of 2022 (H.R.7667) SAVE Act (H.R. 2120) Hospital Inpatient Services Modernization Act (H.R. 7053; S. 3792)

Client expense: $60,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Issues related to COVID-19 research and development, vaccine distribution and manufacturing; Next Generation COVID-19 vaccines and boosters; Issues related to ASPR/BARDA and manufacturing of COVID-10 vaccines and boosters; Issues related to Oncology and HPV cancers; Continuing Resolution (CR), H.R. 6833, the Continuing Resolution and Ukraine Supplemental Appropriations Act; FY2023 Omnibus Appropriations Act, H.R. 2617; Issues related to the Prescription Drug User Fee Act (PDUFA); Issues related to the Medical Device User Fees Amendment (MDUFA IV); ARPA-H Act, H.R 5585; Accelerated Approval Integrity Act of 2022, H.R. 6963; Prevent Pandemic Act, S. 3799; DNA Medicines awareness

Client expense: $130,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office

COVID Supplemental Appropriation FY2023 Defense Appropriations S.2076/H.R.3932 - PASTEUR Act of 2021 S.3799 - PREVENT Pandemics Act Issues related to the development of an antibody therapy for COVID-19 Issues related to antimicrobial resistance (AMR) and drug development Issues related to supply chain and biopharmaceutical manufacturing H.R.8236 - Department of Defense Appropriations Act, 2023 H.R.7667 - Food and Drug Amendments of 2022 S.4348 - Food and Drug Administration Safety and Landmark Advancements Act (FDASLA) of 2022 H.R.5585 - Advanced Research Projects Agency - Health (ARPA-H) Act S.3819 - Advanced Research Project Authority for Health (ARPA-H) Act H.R.6833 - Continuing Appropriations and Ukraine Supplemental Appropriations Act, 2023 H.R.2617 - Consolidated Appropriations Act, 2023

Client expense: $210,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Issues related to Health Care Trade and Supply Chain Security. Issues related to AI in Health Care. Issues related to Department of Health and Human Services Appropriations. Issues related to research and development tax policy. HR 1846, To amend the Public Health Service Act with respect to hospital infrastructure, all provisions. HR 4479 / S 2609, Facilitating Innovative Nuclear Diagnostics Act of 2021, all provisions. S 2107, Facilitating American-Built Semiconductors Act, all provisions. HR 7253, Clarifying Remanufacturing to Protect Patient Safety Act of 2022, all provisions. HR 5585, Advanced Research Projects Agency - Health Act, all provisions. S 3983 / HR 7084, PATCH Act of 2022, all provisions. HR 7667, Food and Drug Amendments of 2022, all provisions. HR 4521 / S 1260, United States Innovation and Competition Act of 2021, all provisions. S 2533 / HR 4794, Making Advances in Mammography and Medical Options for Veterans Act, all provisions. S 2102, Dr. Kate Hendricks Thomas SERVICE Act, all provisions. HR 4571, Supporting Expanded Review for Veterans In Combat Environments Act of 2021, all provisions. HR 2617, Consolidated Appropriations Act, 2023, provisions pertaining to health care cyber security, medical contrast and diagnostic radiopharmaceutical regulation, and HHS ASPR Hospital Preparedness Program appropriations. S 3799, PREVENT Pandemics Act, provisions pertaining medical device shortage reporting.

Client expense: $1,440,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Medicaid program reforms, including telemedicine Section 340B Drug Pricing Program Sickle cell disease research funding generally Drug pricing reforms generally Reauthorization of Children's Hospital Graduate Medical Education program Mental and behavioral health legislation generally H.R. 4943 (Children's Mental Health Infrastructure Act of 2021), all provisions H.R. 4944 (Helping Kids Cope Act of 2021), all provisions H.R. 5585 (Advanced Research Project Agency-Health Act), all provisions H.R. 7236 (Strengthen Kids' Mental Health Now Act of 2022), all provisions H.R. 7666 (Restoring Hope for Mental Health and Well-Being Act of 2022), all provisions H.R. 6972 (Give Kids a Chance Act of 2022), all provisions S. 4348 (FDASLA Act of 2022), Title VIII, Subtitle C, regarding regulation of in vitro clinical tests H.R. 7667 (Food and Drug Amendments of 2022), all provisions S. 4472 (Health Care Capacity for Pediatric Mental Health Act of 2022), all provisions S. 4747 (Investing in Kids Mental Health Now Act of 2022), all provisions Children's Health Insurance Program (CHIP), regarding continuous eligibility

Client expense: Not reported · Firm income: $50,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Medicaid program reforms, including telemedicine Section 340B Drug Pricing program Drug pricing reforms generally Juvenile mental and behavioral health legislation generally H.R. 4943 (Children's Mental Health Infrastructure Act of 2021), all provisions H.R. 4944 (Helping Kids Cope Act of 2021), all provisions H.R. 5585 (Advanced Research Project Agency-Health Act), all provisions H.R. 7236 (Strengthen Kids' Mental Health Now Act of 2022), all provisions H.R. 7666 (Restoring Hope for Mental Health and Well-Being Act of 2022), all provisions S. 4472 (Health Care Capacity for Pediatric Mental Health Act of 2022), all provisions Reauthorization of Children's Hospital Graduate Medical Education (CHGME) program "Food as medicine" nutrition programs generally Children's Health Insurance Program (CHIP), regarding continuous eligibility

Client expense: Not reported · Firm income: $40,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

FDA approval paths. Health care reform. Drug pricing policy. Reimbursement policy. H.R. 4043 - Ensuring Patient Access to Critical Breakthrough Products Act. Proposals for Advanced Research Project Agency-Health; H.R. 5585 - ARPA-H Act. H.R. 6000 - Cures 2.0 Act.

Client expense: Not reported · Firm income: $60,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

FDA Safety and Landmark Advancements (FDASLA) Act (S. 4348); Food and Drug Amendments of 2022 (H.R. 7667); Diverse and Equitable Participation in Clinical Trials Act (H.R. 6584); Advanced Research Project Agency-Health Act (H.R. 5585); America COMPETES Act of 2022 (H.R. 4521); Interagency Patent Coordination and Improvement Act of 2022 (S. 4430); Increasing Prescription Drug Competition Act (S. 4918); Consolidated Appropriations Act, 2023 (H.R. 2617); PASTEUR Act of 2021 (H.R. 3932/S. 2076); Biologics Competition Act of 2022 (H.R. 8877); Give Kids a Chance Act of 2022 (S. 4125/H.R. 6972); Orange Book listing issues; Bayh-Dole Act.

Client expense: Not reported · Firm income: $100,000

Discussions regarding the implementation of COVID-19 related emergency legislation (H.R.748, H.R.6102, H.R.6074) regarding the role of AI and machine learning to assist in response and recovery from COVID-19 pandemic. Leveraging analytics in unemployment programs; infection control; telehealth; hospital data reporting requirements. Outreach/meetings on PREVENT Pandemics Act (S.3799) and ARPA-H Authorization (S.3819, H.R.5585, H.R.6000)

Client expense: $540,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Office of Science & Technology Policy (OSTP), SENATE

Issues related to the development of therapies for rare diseases and sleep disorders; drug pricing; access to non-controlled medications; PDUFA Reauthorization; H.R.6000, Cures 2.0 Act; FY2022 Budget Reconciliation/Inflation Reduction Act of 2022 (H.R.5376, P.L.117-169); H.R.5585, Advanced Research Project Agency-Health Act; H.R.6963, Accelerated Approval Integrity Act of 2022; H.R.2623, Camerons Law; H.R.7667, Food and Drug Amendments of 2022; S.4348, FDASLA Act of 2022; H.R.6833, Making continuing appropriations for fiscal year 2023, and for other purposes (P.L.117-180); H.R.8641, Orphan Drug COVID-19 Mitigation Act of 2022; H.R. 1730/S. 670, The Speeding Therapy Access Today (STAT) Act of 2021.

Client expense: $250,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Medicaid program reforms, including telemedicine Section 340B Drug Pricing program Drug pricing reforms generally Juvenile mental and behavioral health legislation generally H.R. 4943 (Children's Mental Health Infrastructure Act of 2021), all provisions H.R. 4944 (Helping Kids Cope Act of 2021), all provisions H.R. 5585 (Advanced Research Project Agency-Health Act), all provisions H.R. 7236 (Strengthen Kids' Mental Health Now Act of 2022), all provisions H.R. 7666 (Restoring Hope for Mental Health and Well-Being Act of 2022), all provisions S. 4472 (Health Care Capacity for Pediatric Mental Health Act of 2022), all provisions H.R. 3089/S. 1544 (Accelerating Kids' Access to Care Act), all provisions Reauthorization of Children's Hospital Graduate Medical Education (CHGME) program "Food as medicine" nutrition programs generally Children's Health Insurance Program (CHIP), regarding continuous eligibility H.R. 4128/S.2209 (VALID Act of 2021)

Client expense: $160,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Medicaid program reforms, including telemedicine Section 340B Drug Pricing Program Sickle Cell Disease research funding generally Drug pricing reforms generally Reauthorization of Children's Hospital Graduate Medical Education program Mental and behavioral health legislation generally H.R. 4943 (Children's Mental Health Infrastructure Act of 2021), all provisions H.R. 4944 (Helping Kids Cope Act of 2021), all provisions H.R. 5585 (Advanced Research Project Agency-Health Act), all provisions H.R. 7236 (Strengthen Kids' Mental Health Now Act of 2022), all provisions H.R. 7666 (Restoring Hope for Mental Health and Well-Being Act of 2022), all provisions H.R. 6972 (Give Kids a Chance Act of 2022), all provisions H.R. 7667 (Food and Drug Amendments of 2022), all provisions H.R. 5131 and S. 2762 (PATCH Act), all provisions H.R. 1916 (Ensuring Lasting Smiles Act), all provisions S. 4348 (FDASLA Act of 2022), Title VIII, Subtitle C, regarding regulation of in vitro clinical tests S. 4472 (Health Care Capacity for Pediatric Mental Health) S. 4747 (Investing in Kids Mental Health Now Act) Children's Health Insurance Program (CHIP), regarding continuous elgibility

Client expense: $118,118 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Issues related to the development of therapies for rare diseases and sleep disorders. Drug pricing. Access to non-controlled medications. PDUFA Reauthorization. H.R.6000 - Cures 2.0 Act. FY2022 Budget Reconciliation/Inflation Reduction Act of 2022 (H.R.5376, P.L.117-169). H.R.5585 - Advanced Research Project Agency-Health (ARPA-H) Act. H.R.6963 - Accelerated Approval Integrity Act of 2022. H.R.2623 - Camerons Law. H.R.7667 - Food and Drug Amendments of 2022. S.4348 - FDASLA Act of 2022. H.R.6833 - Making continuing appropriations for fiscal year 2023, and for other purposes (P.L.117-180). H.R.8641 - Orphan Drug COVID-19 Mitigation Act of 2022. H.R.1730/S.670 - Speeding Therapy Access Today (STAT) Act of 2021. Issues related to raising awareness of World Narcolepsy Day.

Client expense: Not reported · Firm income: $50,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Issues related to the development of therapies for rare diseases and sleep disorders. Drug pricing. Access to non-controlled medications. PDUFA Reauthorization. H.R.6000 - Cures 2.0 Act. FY2022 Budget Reconciliation/Inflation Reduction Act of 2022 (H.R.5376, P.L.117-169). H.R.5585 - Advanced Research Project Agency-Health (ARPA-H) Act. H.R.6963 - Accelerated Approval Integrity Act of 2022. H.R.2623 - Camerons Law. H.R.7667 - Food and Drug Amendments of 2022. S.4348 - FDASLA Act of 2022. H.R.6833 - Making continuing appropriations for fiscal year 2023, and for other purposes (P.L.117-180). H.R.8641 - Orphan Drug COVID-19 Mitigation Act of 2022. H.R.1730/S.670 - Speeding Therapy Access Today (STAT) Act of 2021.

Client expense: Not reported · Firm income: $50,000

Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE

Pandemic and Covid-19 preparedness; S. 3799 PREVENT Pandemics Act; CURES 2.0 legislation; H.R. 5585 - ARPA-H Act; Pandemic and All Hazards Preparedness Act Reauthorization.

Client expense: Not reported · Firm income: $20,000

P.L. 116-136, Coronavirus Aid, Relief, and Economic Security (CARES) Act - provisions related to infusion issues for Medicare patients, amendments to the Tax Cuts and Jobs Act (TCJA), plasma awareness, and the orphan drug tax credit; Issues related to patient access of plasma therapies; Discussions to clarify or reform the 340B program; Discussions on value-based drug contracting; Issues related to prescription drug vial sizes; Proposals related to drug pricing, including House and Senate draft bills; Discussions related to co-pay accumulators; maximizers, alternate funding models; H.R. 6000, Cures 2.0 Act - provisions related to the pharmaceutical industry; Discussions related to amending P.L. 97-414, Orphan Drug Act; Proposed FDA guidance on gastroparesis clinical trials; Bayh-Dole march-in rights policy issues; Advisory Committee on Heritable Disorders in Newborns and Children - issues related to newborn screening; H.R. 482, S. 350, Newborn Screening Saves Lives Reauthorization of 2021 - provisions related to newborn screening; Discussions related to Most Favored Nation/International Reference Pricing; H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act - provisions related to lower prescription drug prices; S. 1281, To amend the CARES Act to expand a national awareness and outreach campaign to address the importance and safety of plasma donation, and for other purposes - provisions related to plasma donation; H.R. 3468, S. 1281, Plasma Donation Awareness Act - provisions related to requiring HHS to initiate a plasma donation awareness campaign much like the one required for blood donation in P.L. 116-136 (CARES Act); H.R. 2163, S. 464, Safe Step Act - provisions related to step therapy policy; H.R. 19, Lower Costs, More Cures Act of 2021 - provisions related to AMP cap removal, Medicare Part D redesign, exclusivity periods, vial wastage, drug price transparency, add-on payment and pay-fors; H.R. 5260, Reduced Costs and Continued Cares Act - provisions related to prescription drug prices; Food and Drug Amendments of 2022 - provisions related to the reauthorization of Prescription Drug User Fee Act (PDUFA) and the Biosimilars User Fee Amendments (BsUFA), clinical trial diversity, and accelerated approval provision; S. 4348, FDASLA Act of 2022 - provisions related to the reauthorization of Prescription Drug User Fee Act (PDUFA) and the Biosimilars User Fee Amendments (BsUFA), clinical trial diversity, and accelerated approval provision; H.R. 5416, Give Kids a Chance Act - provisions related to establishing additional authorities of the FDA regarding the conduct of pediatric investigations of molecularly targeted drugs to treat cancer, and for other purposes; H.R. 6584, DEPICT Act - provisions related to amending certain FDA regulations to increase clinical trial diversity; H.R. 5585, Advanced Research Project Agency-Health Act - provisions related to the establishment of the Advanced Research Projects Agency-Health to accelerate innovation in health and medicine by investing in high-risk, high-reward research projects; H.R. 6963, Accelerated Approval Integrity Act of 2022 - provisions related to strengthening requirements for post approval studies for drugs approved using accelerated approval; S. 3799, PREVENT Pandemics Act - provisions related to pandemic readiness; Discussions on Customs Border Protection changes impacting southern border plasma collections; Discussions to establish a Congressional Plasma Caucus; Discussions related to Cancer Moonshot Initiatives; S. 4293, Pharmacy Benefit Manager Transparency Act of 2022 - provisions related to data protection; Issues related to Dengue vaccines;

Client expense: $780,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

HR 5376 Inflation Reduction Act of 2022. Provisions related to health care coverage, Medicare, Medicaid, COVID funding and mental/behavioral health S. 3700 Affordable Insulin Act Now HR 7667 FDA Amendments of 2022 S 4348 The FDA Safety and Landmark Advancements Act HR 6963 Accelerated Approval Integrity Act of 2022 HR 6996 Accelerating Access for Patients Act of 2022 HR 5585 Advanced Research Project Agency Health (ARPA-H) Act HR 6000 Cures 2.0 Act

Client expense: $180,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

H.R.5526, the Resident Physician Shortage Act; H.R. 3441 the Substance Use Disorder Workforce Act; H.R. 5376, the Consolidated Appropriations Act, 2021; Medicaid Directed Payments Policies H.R. 5585, the Advanced Research Project Agency-Health Act

Client expense: $111,983 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Support policies to remove barriers to clinical trials, promote research generally, address issues in childhood cancer research including HR5030 / S2706 - The Diversifying Investigations Via Equitable Research Studies for Everyone (DIVERSE) Trials Act; HR623 / S1521 - Gabriella Miller Kids First Research Act 2.0; HR3089 / S1544 Accelerating Kids Access to Care Act; HR 6000, CURES 2.0 Act; H.R. 5585, the Advanced Research Project Agency-Health (ARPA-H) Act and reform of the oversight of Laboratory Developed Tests as outlined in S.2209/HR 4128 the VALID Act and S 3799 the PREVENT Pandemics Act.

Client expense: $122,569 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Office of Science & Technology Policy (OSTP), SENATE

Issues related to the development of therapies for rare diseases and sleep disorders; drug pricing; access to non-controlled medications; PDUFA Reauthorization; H.R.6000, Cures 2.0 Act; FY2022 Budget Reconciliation/Inflation Reduction Act of 2022 (H.R.5376, P.L.117-169); H.R.5585, Advanced Research Project Agency-Health Act; H.R.6963, Accelerated Approval Integrity Act of 2022; H.R.2623, Camerons Law; H.R.7667, Food and Drug Amendments of 2022; S.4348, FDASLA Act of 2022; H.R.6833, Making continuing appropriations for fiscal year 2023, and for other purposes (P.L.117-180); H.R.8641, Orphan Drug COVID-19 Mitigation Act of 2022; H.R. 1730/S. 670, The Speeding Therapy Access Today (STAT) Act of 2021.

Client expense: $250,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Issues related to diversity in clinical trials, Alzheimers research, and HR 5585, the ARPA-H Act.

Client expense: Not reported · Firm income: $24,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.J. Res. 19, Proposing an amendment to the Constitution of the United State to repeal the twenty-third article of amendment to the Constitution of the United States S.J. Res. 18, A joint resolution proposing an amendment to the Constitution of the United States to repeal the twenty-third article of amendment to the Constitution of the United States H. Res. 370, Expressing the sense of the House of Representatives supporting the Federal workforce H. Res. 544, Acknowledging and apologizing for the mistreatment of, and discrimination against, lesbian, gay, bisexual, and transgender individuals who served the United States in the armed Forces, the Foreign Service, and the Federal civil service S. Res. 275, A resolution acknowledging and apologizing for the mistreatment of, and discrimination against, lesbian, gay, bisexual, and transgender individuals who served the United States in the Armed Forces, the Foreign Service, and the Federal civil service H. Res. 766, Recognizing law enforcement officers who have tragically passed away from COVID-19 pandemic H. Res. 937, Recognizing the duty of the Federal Government to preserve liberty by operating within the enumerated powers in the Constitution of the United States and its founding principles H. Res. 1367, Providing for the consideration of the bill (H.R. 82) to amend title II of the Social Security Act to repeal the Government pension offset and windfall elimination provisions H.R. 5, Equality Act S. 393, Equality Act H.R. 25, Fair Tax Act of 2021 H.R. 51, Washington, D.C. Admission Act S. 51, Washington, D.C. Admission Act H.R. 82, Social Security Fairness Act of 2021 S. 1302, Social Security Fairness Act H.R. 103, Bonuses for Cost-Cutters Act of 2021 H.R. 111, Federal Sunset Act of 2021 H.R. 212, COVID PREPARE Act of 2021 H.R. 221, To amend title 5, United States Code, to modify the oath of office taken by individuals in the civil service or uniformed services, and for other purposes H.R. 222, Election Day Holiday Act of 2021 H.R. 236, To nullify the effect of Executive Order 13950 relating to combating race and sex stereotyping H.R. 244, Executive Branch Conflict of Interest Act H.R. 269, Putting Our Resources Toward Security (PORTS) Act H.R. 302, PPSA Act S. 4702, PPSA Act of 2022 H.R. 304, Equal COLA Act S. 4221, Equal COLA Act H.R. 326, Saving the Civil Service Act H.R. 348, Wear Your Mask Act H.R. 353, Security Clearance Improvement Act of 2021 H.R. 356, Federal HIRE Act H.R. 375, No Mask Mandates Act H.R. 393, Federal Firefighter Pay Equity Act H.R. 408, Department of Homeland Security Mentor-Protege Program Act of 2021 H.R. 490, DHS MORALE Act H.R. 521, First Responder Fair RETIRE Act S. 129, First Responder Fair RETIRE Act H.R. 531, ICE and CBP Body Camera Accountability Act H.R. 564, Comprehensive Paid Leave for Federal Employees Act S. 1158, Comprehensive Paid Leave for Federal Employees Act H.R. 916, REDUCE Act H.R. 938, Wildland Firefighter Recognition Act S. 1221, Wildland Firefighters Recognition Act H.R. 962, Law Enforcement Officers Equity Act S. 1888, Law Enforcement Officers Equity Act H.R. 967, Federal Skills Act H.R. 978, Chai Suthammanont Remembrance Act of 2021 S. 2343, Chai Suthammanont Remembrance Act of 2021 H.R. 8466, Chai Suthammanout Remembrance Act of 2022 H.R. 1136, Federal Jobs Act H.R. 1200, Stop CHEATERS Act S. 1857, Stop CHEATERS Act H.R. 1224, Merit Systems Protections Board Empowerment Act of 2021 H.R. 1272, COST of Relocation Act S. 392, COST of Relocations Act H.R. 1459, Ultra-Millionaire Tax Act of 2021 S. 510, Ultra-Millionaire Tax Act of 2021 H.R. 1468, Securities and Exchange Commission Real Estate Leasing Authority Revocation Act H.R. 1481, Cost of Police Misconduct Act of 2021 S. 540, Cost of Police Misconduct Act of 2021 H.R. 1690, Defending Our Defenders Act H.R. 1922, Merit Systems Protection Board Reauthorization Act of 2021 H.R. 2042, Federal Employee Access to Information Act S. 845, Federal Employee Access to information Act H.R. 2104, RECAL Act H.R. 2199, Federal Agency Sunset Commission Act of 2021 H.R. 2231, Shielding All Federal Employees and Consumers from Actionable Recall Situations Act of 2021 H.R. 2337, Public Servants Protection and Fairness Act of 2021 H.R. 2345, Federal Government Decentralization Commission Act H.R. 2414, Keep Vaccines Voluntary Act H.R. 2499, Federal Firefighters Fairness Act of 2021 S. 1116, Federal Firefighters Fairness Act of 2021 H.R. 2566, No TikTok on Government Devices Act S. 1143, No TikTok on Government Devices Act H.R. 2589, Family Medical Leave Modernization Act S. 1185, Family Medical Leave Modernization Act H.R. 2617, Performance Enhancement Reform Act H.R. 2744, Hazardous Duty Pay for Frontline Workers Act H.R. 2776, Border Patrol Agent Pay Reform Amendments Act of 2021 H.R. 2954, Securing a Strong Retirement Act of 2021 H.R. 2988, Whistleblower Protection Improvement Act of 2021 H.R. 3000, Inspire to Serve Act of 2021 H.R. 3028, LPOE Modernization Trust Fund Act H.R. 3040, Pandemic Leave Extension Act H.R. 3045, No Regulation Through Litigation Act of 2021 H.R. 3050, Kenneth Meisel Public Servants' Claimant Fairness Act H.R. 3070, COPS Counseling Act H.R. 3079, Protect and Serve Act of 2021 S. 774, Protect and Serve Act of 2021 H.R. 3080, Back the Blue Act of 2021 S. 1599, Back the Blue Act of 2021 H.R. 3086, Locality Pay Equity Act of 2021 S. 1561, Locality Pay Equity Act of 2021 H.R. 3096, Federal Law Enforcement Officer Service Weapon Purchase Act S. 4150, Federal Law Enforcement Service Weapon Purchase Act H.R. 3172, HELPER Act of 2021 S. 2981, HELPER Act of 2021 H.R. 3179, Stop CRT Act H.R. 3235, To restrict executive agencies from acting in contravention of Executive Order 13950 H.R. 3249, Contents of Our Character Act of 2021 H.R. 3295, Prohibiting TSP Investment in China Act S. 1665, Prohibiting TSP Investment in China Act H.R. 3338, Enhanced Whistleblower Engagement Act H.R. 3351, To amend title 5, United States Code, to correct a legislative drafting error in such title, to eliminate the reduction in pay of a Federal employee or D.C. employee as a result of such employee serving as a member of the National Guard of the District of Columbia, and for other purposes H.R. 3367, Gold Star Children Act H.R. 3499, MERIT Act H.R. 3533, To establish occupational series for Federal positions in software development, software engineering, data science, and data management, and for other purposes H.R. 3553, TSP Act S. 1742, TSP Act H.R. 3557, Homeland Security Improvement Act H.R. 3609, Trust in Public Service Act S. 1934, Trust in Public Service Act H.R. 3610, Flexibility in Working Families Act H.R. 3768, Federal Employee Disclosure (FED) Transparency Act H.R. 3924, U.S. Park Police Modernization Act H.R. 4031, Retain Skilled Veterans Act S. 2161, Retain Skilled Veterans Act H.R. 4094, One-Stop Pilot Program Act of 2021 H.R. 4105, Restoring Northern Border Travel Act H.R. 4138, CBP Workload Staffing Model Act H.R. 4268, Federal Retirement Fairness Act H.R. 4274, Wildland Firefighter Fair Pay Act H.R. 4315, Fair COLA for Seniors Act of 2021 H.R. 4349, Department of Homeland Security Office for Civil Rights and Civil Liberties Act H.R. 4357, DHS Reform Act of 2021 H.R. 4389, New Collar Jobs Act of 2021 H.R. 4396, Holding SSA Employees Accountable Act H.R. 4448, Administrative Law Judges Competitive Service Restoration Act H.R. 4576, Support Through Loss Act S. 2390, Support Through Loss Act H.R. 4594, Restoring Brand USA Act S. 2424, Restoring Brand USA Act H.R. 4604, To allow certain individuals with prior service under the District of Columbia retirement system to make deposits towards annuities under the Civil Service Retirement System and the Federal Employees Retirement System, and for other purposes H.R. 4666, Public Service Loan Forgiveness Modernization Act H.R. 4688, Federal Agency Customer Experience Act of 2021 S. 671, Federal Agency Customer Experience Act of 2021 H.R. 4724, Strengthening Loan Forgiveness for Public Servants Act S. 2478, Strengthening Loan Forgiveness for Public Servants Act H.R. 4725, No Student Loan Interest Act H.R. 4728, Thirty-Two Hour Workweek Act H.R. 4773, Consumer Financial Protection Commission Act H.R. 4788, Wellbeing for Every Public Servant Act of 2021 H.R. 4818, National Digital Reserve Corps Act H.R. 4840, End Misleading Cultural Exchanges Act H.R. 4884, Employee Rights and Freedoms Act H.R. 4934, Equal Pay for Equal Work Act S. 2591, Equal Pay for Equal Work Enforcement Act H.R. 5031, Sarah Grace-Farley-Klinger Act H.R. 5057, Return Act S. 2681, Return Act H.R. 5092, To prohibit the Federal Government from requiring any citizen to be vaccinated, including Federal agencies from requiring its employees to take any vaccination, without the citizen being fully advised in writing of all known potential risks from the vaccine and consultation with a physician followed by the voluntary informed consent of the citizen, and for other purposes H.R. 5106, To prohibit an entity that receives Federal funds from the COVID relief packages from mandating employees receive a COVID-19 vaccine, and for other purposes H.R. 5113, REMEDI Act H.R. 5138, Federal Cybersecurity Workforce Expansion Act S. 2274, Federal Cybersecurity Workforce Expansion Act H.R. 5206, To require the Internal Revenue Service to issue a report on the tax gap, to establish a fellowship program within the Internal Revenue Service to recruit mid-career tax professionals to create and participate in an audit task force, and for other purposes S. 2721, To require the Internal Revenue Service to issue a report on the tax gap, to establish a fellowship program within the Internal Revenue Service to recruit mid-career tax professionals to create and participate in an audit task force, and for other purposes H.R. 5238, Grandparent-Grandchild Medical Leave Act H.R. 5274, PREVENT ACT of 2021 H.R. 5282, Care for our Firefighters Act H.R. 5283, Housing for our Firefighters Act H.R. 5287, COVID-19 Vaccine Developers Gold Medal Act H.R. 5303, September 11 Day of Remembrance Act S. 2735, September 11 Day of Remembrance Act H.R. 5314, Protecting Our Democracy Act H.R. 5360, Freedom from Mandates act H.R. 5364, Protect Taxpayers' Privacy Act H.R. 5408, A bill for the relief of Michael Janssen and Steven Passantino S. 3442, A bill for the relief of Michael Janssen and Steven Passantino H.R. 5450, To prohibit the use of Federal funds to implement or enforce a COVID-19 vaccine mandate, and for other purposes H.R. 5456, Federal Employees Civil Relief Act S. 2900, Federal Employees Civil Relief Act H.R. 5464, No Taxation Without Congressional Consent Act H.R. 5477, Federal Agency Climate PREP Act S. 3156, Federal Agency Climate PREP Act of 2021 H.R. 5494, Protect Peaceful Protests Act H.R. 5513, No Clearance for Terrorists Act H.R. 5585, Advanced Research Project Agency-Health Act H.R. 5590, Natural Immunity is Real Act H.R. 5592, FREEDOM Act H.R. 5613, Let Me Travel America Act S. 2847, Let Me Travel America Act H.R. 5616, DHS Basic Training Accreditation Improvement Act of 2021 H.R. 5631, Tim Hart Wildland Firefighter Classification and Pay Parity Act H.R. 5637, Meeting our Seniors' Social Security Needs Act H.R. 5642, Follow Accepted Science Together Act of 2021 H.R. 5662, SWAMP Act H.R. 5682, CBP Donations Acceptance Program Reauthorization Act H.R. 5683, Department of Homeland Security Border Support Services Contracts Review Act H.R. 5686, Don't Jab Me Act S. 2840, Don't Jab Me Act H.R. 5687, Backing the Independent Decisions of Employees against Nefarious Mandates Act of 2021 H.R. 5712, Drain the Swamp Act of 2021 H.R. 5717, Stop the SURGE Act H.R. 5723, Social Security 2100: A Sacred Trust S. 3071, Social Security 2100: A Sacred Trust H.R. 5737, Social Security for Future Generations Act of 2021 H.R. 5741, Options Over Terminations Act H.R. 5744, Customer Non-Discrimination Act H.R. 5811, No Vaccine Mandate Act H.R. 5816, National Informed Consent Exemption (NICE) Act H.R. 5824, Mandating Responsibility Act H.R. 5829, COVID-19 Individual Liberty Act of 2021 H.R. 5834, Equal Treatment of Public Servants Act of 2021 H.R. 5835, Defund Federal Vaccine Mandates Act H.R. 5842, Ending the Monopoly of Power Over Workplace Harassment through Education and Reporting Act H.R. 5860, Keeping Our COVID-19 Heroes Employed Act S. 3079, Keeping Our COVID-19 Heroes Employed Act H.R. 5866, Protection of Social Security Benefits Restoration Act S. 3177, Protection of Social Security Benefits Restoration Act H.R. 5903, HERD Act S. 3095, HERD Act of 2021 H.R. 5908, Stop Vaccine Mandates Act S. 2879, Stop Vaccine Mandates Act H.R. 5927, Veterans' Preference Parity Act H.R. 5978, Exemptions for Critical Workers Act H.R. 5994, BE HEARD in the Workplace Act S. 3219, BE HEARD in the Workplace Act H.R. 6009, Pandemic Cessation Act H.R. 6031, HEALING Mothers and Fathers Act S. 3253, HEALING Mothers and Fathers Act H.R. 6062, Hatch Act Accountability Act H.R. 6066, Strengthening the Office of Personnel Management Act H.R. 6085, Fair Pay for All Act of 2021 H.R. 6087, Improving Access to Workers Compensation for Injured Federal Workers Act H.R. 6104, Building the Next Generation of Federal Employees Act H.R. 6105, To terminate the public health emergency with respect to COVID-19 on December 25, 2021 H.R. 6107, Stop Corporate Capture Act H.R. 6113, Employee Privacy Act H.R. 6170, No COVID-19 Vaccination Mandate Act of 2021 H.R. 6185, Bivens Act of 2021 S. 3343, Bivens Act of 2021 H.R. 6212, Taiwan Preclearance Act S. 3312, Taiwan Preclearance Act H.R. 6223, BASE Act H.R. 6257, SAFER Travel Act H.R. 6264, POLICE Act of 2021 H.R. 6275, To prohibit the use of Federal funds to administer a COVID-19 vaccine to officers and employees of the U.S. Border Patrol, U.S. Immigration and Customs Enforcement, or certain Department of the Interior officers and employees or require that such officers and employees receive a vaccine as a condition of employment H.R. 6288, To establish certain protections for members of the Armed Forces who refuse to receive vaccinations against COVID-19 H.R. 6304, Stop Federal Vaccine Mandates for Employees Act H.R. 6327, Constitutional Accountability Act S. 3415, Constitutional Accountability Act H.R. 6333, To prohibit the use of Federal funds to establish, or support any national database identifying individuals as having received or not received any vaccine H.R. 6395, No Mandates Act H.R. 6398, FAIR Act S. 3518, FAIR Act H.R. 6409, Repeal CFPB Act S. 1090, Repeal CFPB Act H.R. 6492, Climate Resilience Workforce Act H.R. 6502, Religious Freedom Over Mandates Act H.R. 6579, Teamwork for Employees and Managers Act of 2022 S. 3585, Teamwork for Employees and Managers Act of 2022 H.R. 6581, Bipartisan Social Security Commission Act of 2022 H.R. 6590, Senior Citizens Tax Elimination Act H.R. 6594, Protecting Federal Agencies and Employees from Political Interference Act of 2022 H.R. 6609, FACE Act H.R. 6670, Schedules That Work Act S. 3642, Schedules That Work Act H.R. 6674, To prohibit Internal Revenue Service from requiring individuals to submit biometric information or geolocation information to access online services, and for other purposes H.R. 6694, STOCK Act 2.0 S. 3612, STOCK Act 2.0 H.R. 6733, Ban IRS Biometrics Act S. 3599, Ban IRS Biometrics Act H.R. 6800, IRS PRIORITIES Act of 2022 H.R. 6837, No TikTok on Department of Homeland Security Devices Act H.R. 6844, Restoring Trust in Public Servants Act H.R. 6924, Pandemic Payroll Tax Suspension Act H.R. 6932, Federal Employees Short-Term Disability Insurance Act of 2022 H.R. 6938, Job Protection Act S. 3748, Job Protection Act H.R. 6941, Territorial Representation in the Senate Act H.R. 6957, To expand opportunities for employment of recent graduates in Federal Government positions, and for other purposes H.R. 6966, Better Service for Taxpayers Act H.R. 6967, Chance to Compete Act of 2022 S. 3423, Chance to Compete Act of 2021 H.R. 7036, Preventing Abusive Government Efforts Act H.R. 7113, TSP Act of 2022 H.R. 7134, Taxpayers DIME Act of 2022 H.R. 7260, Comprehensive Southern Border Strategy Act H.R. 7287, Anti-Border Corruption Improvement Act H.R. 7365, Flexibility for Workers Education Act H.R. 7376, Honoring Civil Servants Killed in the Line of Duty Act S. 3474, Honoring Civil Servants Killed in the Line of Duty Act S. 3487, Honoring Civil Servants Killed in the Line of Duty Act H.R. 7423, America Reopens Act H.R. 7459, DHS Rural and Remote Hiring and Retention Strategy Act of 2022 H.R. 7465, PSLF Payment Completion Fairness Act H.R. 7485, Simplify, Don't Amplify the IRS Act H.R. 7489, Time Off to Vote Act H.R. 7530, Student Loan Borrower Relief Act H.R. 7540, Safe Workplaces Act H.R. 7557, Department of the Treasury Officer Protection Act of 2022 H.R. 7567, To amend chapter 77 of title 5, United States Code, to clarify certain due process rights of Federal employees serving in sensitive positions, and for other purposes H.R. 7657, RECOVER Act of 2022 H.R. 7720, SWAMP Act S. 4197, SWAMP Act of 2022 H.R. 7723, To amend the American Rescue Plan Act of 2021 to extend the availability of paid leave for Federal employees for purposes relating to COVID-19, and for other purposes H.R. 7770, Life Saving Leave Act H.R. 7799, Public Servant Protection Act of 2022 H.R. 7804, Law Enforcement Officer Safety and Security Act of 2022 H.R. 7835, SHOW UP Act of 2022 H.R. 7852, Federal Employees Sustainable Investment Act H.R. 7896, No ESG at TSP Act S. 5000, No ESG at TSP Act H.R. 7900, National Defense Authorization Act for Fiscal Year 2023 S. 4543, James M. Inhofe National Defense Authorization Act for Fiscal Year 2023 H.R. 7951, Telework Metrics and Cost Savings Act H.R. 8040, People Over Pentagon Act of 2022 H.R. 8086, Conservation Jobs Act of 2022 H.R. 8087, LEO Fair Retirement Act of 2022 H.R. 8098, To limit eligibility for public service loan forgiveness to borrowers of Federal student loans with incomes below a certain maximum threshold, and for other purposes H.R. 8212, To rescind the Executive Order on Advancing Equality for Lesbian, Gay, Bisexual, Transgender, Queer, and Intersex Individuals, and for other purposes H.R. 8283, Federal Employee Student Debt Transparency Act H.R. 8330, Strengthening and Improving Public Service Loan Forgiveness Act of 2022 H.R. 8368, Tax Filing Simplification Act of 2022 S. 4508, Tax Filing Simplification Act of 2022 H.R. 8464, To require certain agencies in the executive branch of the Federal government to conduct a study on duplicative functions, and for other purposes H.R. 8550, Public Service Reform Act H.R. 8610, Health Security and Countering Weapons of Mass Destruction Act S. 4465, Offices of Countering Weapons of Mass Destruction and Health Security Act of 2022 H.R. 8640, To require the Commissioner of U.S. Customs and Border Protection to establish procedures for conducting maintenance and repair projects at ports of entry at which the Office of Field Operations conducts certain enforcement activities, and for other purposes S. 3903, A bill to require the Commissioner of U.S. Customs and Border Protection to establish procedures for conducting maintenance projects at ports of entry at which the Office of Field Operations conducts certain enforcement and facilitation activities H.R. 8742, RETURN Act S. 3727, RETURN Act H.R. 8759, Bureaucrats to the Border Act H.R. 8763, Federal Retirement Thrift Investment Board Inspector General Act of 2022 H.R. 8772, Block the Tok Act H.R. 9054, End Lockdowns and Vaccine Mandates Act H.R. 9065, Student Loan Earned Relief Act H.R. 9097, Public Service Reward Act H.R. 9125, Safe Leave for Victims of Domestic Violence Act H.R. 9189, Border Airport Enhancement Act of 2022 H.R. 9216, PORTFOLIO Act H.R. 9233, Trust in Government Act of 2022 H.R. 9253, GORAC Act H.R. 9341, IRS Funding Accountability Act S. 5100, IRS Funding Accountability Act H.R. 9351, NRC Survey Act H.R. 9389, To amend title 10, United States Code, to restrict the Secretary of Defense from paying or reimbursing expenses relating to abortion services H.R. 9390, Stop Corporate Capture Act H.R. 9398, U.S. Customs and Border Protection Behavioral Health Act H.R. 9406, Customs and Border Protection Crisis Hardship and Incentive Pay Act of 2022 H.R. 9409, MERIT Act of 2022 H.R. 9465, Civil Service Federal Employee Serving Overseas Pay Equity Act H.R. 9473, To require the Commissioner of U.S. Customs and Border Protection to regularly review and update policies and manuals related to inspections at ports of entry H.R. 9514, To amend the Internal Revenue Code of 1986 to allow for the inclusion of additional expenses in dependent care FSAs, and for other purposes H.R. 9550, TAPS Act H.R. 9613, Preventing Improper Payments Act H.R. 9628, PEACE Act of 2022 S. 5309, PEACE Act of 2022 S. Res. 334, A resolution memorializing those impacted by and lost to the COVID-19 virus. S. Res. 828, A resolution recognizing the end of the COVID-19 pandemic for Federal employees, servicemembers, and contractors S. 191, FALSE Act S. 489, Federal Employees and Retirees with Delinquent Tax Debt Initiative (FERDI) Act S. 1227, CFPB Pay Fairness Act of 2021 S. 1257, AI Scholarship-for-Service Act S. 1324, Civilian Cyber Security Reserve Act S. 1330, Facilitating Federal Employee Reskilling Act S. 1528, Fair Access for Individuals to Receive Leave Act S. 1650, Protect Our Heroes Act of 2021 S. 1745, GENE Act S. 1934, Trust in Public Service Act S. 1993, TSP Fiduciary Security Act S. 2160, RECAL Act of 2012 S. 2196, Restoring Northern Border Travel Act S. 2221, END CRT Act S. 2222, Protect Taxpayers' Privacy Act S. 2225, Federal Skills Act S. 2247, A bill to protect Federal judges, Federal prosecutors, and Federal law enforcement officers from violence and doxing. S. 2248, A bill to increase the penalties for making personal information about a Federal law enforcement officer or other Federal officer available to the public S. 2252, A bill to increase the penalties for ambushing a law enforcement officer S. 2253, A bill to establish a separate criminal offense for targeting an individual based on their status as law enforcement officer S. 2260, A bill to increase the maximum penalties for assaulting Federal officers by 50 percent S. 2282, Unity through Service Act of 2021 S. 2346, Stop CRT Act S. 2527, Disclose Government Censorship Act S. 2532, Congressional Whistleblower Protection Act of 2021 S. 2551, AI Training Act S. 2773, Unleashing American Innovators Act of 2021 S. 2782, Acting on the Annual Duplication Report Act of 2021 S. 2848, Your Health Comes First Act S. 2849, Prohibiting Forced Vaccination for COVID-19 Act S. 2850, Biden Can't Force Me Act S. 2888, U.S. Air Travel Public Safety Act S. 2895, Prevent Unconstitutional Vaccine Mandates for Interstate Commerce Act S. 2935, Parental Bereavement Act of 2021 S. 2955, Department of Defense Improved Hiring Act S. 2987, Denying Pensions to Convicted Child Molesters Act of 2021 S. 3070, Safeguarding American Families and Expanding Social Security Act of 2021 S. 3076, Ban Conflicted Trading at the Fed Act S. 3081, Tax Free Education Act of 2021 S. 3160, Border Accountability, Oversight, and Community Engagement Act S. 3190, Judgment Fund Accountability Act of 2021 S. 3243, Protecting Our Federal Workforce from Forced COVID-19 Vaccination Act S. 3378, Congressional Review of Agency Legal Settlements Act of 2021 S. 3659, Supporting Essential Workers in Retirement Act S. 3668, No Facial Recognition at the IRS Act S. 3694, Continuing Safe Essential Travel Across our Border Act of 2022 S. 3799, PREVENT Pandemics Act S. 3819, ARPA-H Act S. 3850, Securing America's Ports of Entry Act S. 3868, U.S. Customs and Border Protection Officer Retirement Technical Corrections Act S. 4027, Inspired to Serve Hiring Improvements Act S. 4199, Retirement Annuity Supplement Clarity Act S. 4253, Student Loan Accountability Act S. 4342, ASAP Forgiveness Act S. 4345, Simplifying and Strengthening Public Service Loan Forgiveness Act S. 4427, Checks and Balances Act S. 4518, Solving the Border Crisis Act S. 4572, Non-Intrusive Inspection Expansion Act S. 4828, Governmentwide Executive Councils Administration and Performance Improvement Act S. 4832, Increase Reliable Services Now S. 4894, Improving Government Efficiency and Workforce Development through Federal Executive Boards Act of 2022 S. 4910, Federal Human Capital Transparency Act S. 4911, Hiring Proven Performers to the Civil Service Act S. 5114, PREVENT Act of 2022 S. 5136, Protecting Family Caregivers from Discrimination Act of 2022 S. 5311, IRS Customer Service and Transformation Act of 2022

Client expense: $270,000 · Firm income: Not reported

Government targets: Commodity Futures Trading Commission (CFTC), Consumer Financial Protection Bureau (CFPB), Energy, Dept of, Federal Communications Commission (FCC), Federal Retirement Thrift Investment Board, Food & Drug Administration (FDA), General Services Administration (GSA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Internal Revenue Service (IRS), Merit Systems Protection Board, Natl Credit Union Administration (NCUA), Natl Park Service (NPS), Office of Management & Budget (OMB), Office of Personnel Management (OPM), Office of Special Counsel, Office of the Comptroller of the Currency (OCC), Patent & Trademark Office (PTO), SENATE, Securities & Exchange Commission (SEC), Treasury, Dept of, U.S. Customs & Border Protection, White House Office

21st Century Cures Act 2.0 ---H.R.6000: Cures 2.0 Act 340B Drug Discount Program ---Executive Order on Access to Affordable Life-Saving Medications ---Program Implementation & Oversight Biodefense Research, Development and Procurement Issues (Non-Funding) ---Executive Order on Modernizing Influenza Vaccines ---Implementation of the Coronavirus Preparedness and Response Supplemental Appropriations Act for FY 2020 ---Implementation of Pandemic and All-Hazards Preparedness and Advancing Innovation (PAHPAI) Act of 2019 ---Reauthorization of PAHPA ---White House National Biodefense Strategy Biosimilars ---BSUFA Negotiations ---Implementation and Reauthorization of the Biosimilar User Fee Act of 2022 ---Reimbursement Coronavirus (COVID-19) Pandemic ---H.R.834: Pandemics Require Evaluating, Planning, And Responding Effectively (PREPARE) Act ---H.R.2617: Consolidated Appropriations Act of 2023 ---S.2327: Seniors Prescription Drug Relief Act ---S.3799: Prepare for and Respond to Existing Viruses, Emerging New Threats and (PREVENT) Pandemics Act ---COVID-19 Lessons Learned ---COVID-19 Pricing-Related Provisions ---COVID-19 Vaccine Distribution ---Drug Supply Chain Management ---Healthcare Disparities ---Medicare Reimbursement Policies ---Monoclonal Antibody Coverage and Utilization ---Patient Cost-Sharing and Smoothing ---PREP Act COVID-19 Declaration Coverage for Private Sector Procurement ---R&D Funding for Medical Countermeasures ---Restrictions on Intellectual Property Rights ---Senate HELP Pandemic Preparedness White Paper ---Supply Chain Issues ---Temporarily Refundable R&D Credit ---TRIPS Waiver Climate Change ---H.R.2617: Consolidated Appropriations Act of 2023 ---Implementation of the Inflation Reduction Act (IRA) of 2022 Data Privacy ---H.R.8152: American Data Privacy and Protection Act Diagnostics and Personalized Medicine Regulation and Oversight ---H.R.4128/S.2209: VALID Act Diversity & Inclusion ---H.R.3085: Equity in Neuroscience and Alzheimer's Clinical Trials (ENACT) Act of 2021 ---H.R.5030: Diversifying Investigations Via Equitable Research Studies for Everyone (DIVERSE) Trials Act ---H.R.6584: Diverse and Equitable Participation in Clinical Trials (DEPICT) Act ---S.3799: Prepare for and Respond to Existing Viruses, Emerging New Threats and (PREVENT) Pandemics Act ---S.4348: Food and Drug Administration Safety and Landmark Advancements Act of 2022 ---Clinical Trial Diversity Drug Evaluation and Review ---H.R.2617: Consolidated Appropriations Act of 2023 ---H.R.6963: Accelerated Approval Integrity Act ---H.R.6972/S.4215: Give Kids a Chance Act of 2022 ---H.R.6996: Accelerating Approval for Patients Act ---H.R.7008: The Pre-Approval Information Exchange Act ---S.1644: Promising Pathway Act ---S.1645: Accelerated Drug Approval for Prescription Therapies (ADAPT) Act ---S.4185: Retaining Access and Restoring Exclusivity (RARE) Act ---S.4348: Food and Drug Administration Safety and Landmark Advancements Act of 2022 ---COVID-19 Lessons Learned ---Compassionate Use/Expanded Access ---Expedited Pathways ---Innovation Incentives ---Patient-Focused Drug Development ---Prescription Drug User Fee Act (PDUFA) VII Priorities ---Priority Review Voucher Programs ---Reforms to the Accelerated Approval Pathway ---Regulatory Reform & Modernization ---Use of Real-World Evidence Drug Importation ---S.920: A bill to amend the Federal Food, Drug, and Cosmetic Act to allow for the importation of affordable and safe drugs by wholesale distributors, pharmacies, and individuals ---S.4348: Food and Drug Administration Safety and Landmark Advancements Act of 2022 Drug Manufacturing, Quality & Distribution ---H.R.3927/S.2082: Manufacturing API, Drugs, and Excipients (MADE) in America Act ---H.R.6988: Drug Manufacturing Innovation Act ---H.R.7006: Improving the Nations Safe Pharmaceuticals and Excipients by Creating Tools for Inspecting and overseeing Needed Supplies (INSPECTIONS) Act ---H.R.7667: The Food and Drug Amendments of 2022 ---S.4348: Food and Drug Administration Safety and Landmark Advancements Act of 2022 ---Advanced Manufacturing ---Counterfeiting ---Drug Shortages ---Supply Chain Integrity and Traceability Drug Patenting ---H.R.153: Protecting Consumer Access to Generic Drugs Act of 2021 ---H.R.2873: Affordable Prescriptions for Patients Through Promoting Competition Act of 2021 ---H.R.2883/S.1485: Stop Stalling Access to Affordable Medications ---H.R.2884: Affordable Prescriptions for Patients Through Improvements to Patent Litigation Act of 2021 ---H.R.2891/S.1428: Preserve Access to Affordable Generics and Biosimilars Act ---S.1435: Affordable Prescriptions for Patients Act of 2021 ---S.4430: Interagency Patent Coordination and Improvement Act of 2022 ---Restrictions on Intellectual Property Rights Drug Pricing ---H.R.2617: Consolidated Appropriations Act of 2023 ---H.R.3: Elijah E. Cummings Lower Drug Costs Now Act ---H.R.19/S.2164: Lower Costs, More Cures Act of 2021 ---H.R.2139/S.908: Medicare Drug Price Negotiation Act ---H.R.2148/S.909: Prescription Drug Price Relief Act ---H.R.7667: The Food and Drug Amendments of 2022 ---H.R.9127: Mandating Exclusive Review of Individual Treatments (MERIT) Act ---H.R.9358: Access to Innovative Treatments Act of 2022 ---S.1388: Prescription Pricing for the People Act of 2021 ---S.1435: Affordable Prescriptions for Patients Act of 2021 ---S.4293: Pharmacy Benefit Manager Transparency Act of 2022 ---S.4348: Food and Drug Administration Safety and Landmark Advancements Act of 2022 ---CMMI Authority ---COVID-19 Pricing-Related Provisions ---Implementation of the Inflation Reduction Act (IRA) of 2022 ---National Coverage Determination Foreign Drug Data Protection Laws ---Regulatory Harmonization Funding for Antimicrobial Resistance (AMR) Programs ---H.R.2617: Consolidated Appropriations Act of 2023 ---H.R.3932/S.2076: Pioneering Antimicrobial Subscriptions to End Upsurging Resistance (PASTEUR) ---H.R.4127: DISARM Act ---H.R.7900: National Defense Authorization Act for FY 2023 ---S.4543: James M. Inhofe National Defense Authorization Act for FY 2023 ---Implementation of the Coronavirus Preparedness and Response Supplemental Appropriations Act for FY 2020 Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement ---H.R.2617: Consolidated Appropriations Act of 2023 ---Funding for Strategic National Stockpile ---Health Defense Operations Funding Designation ---Implementation of the Coronavirus Preparedness and Response Supplemental Appropriations Act for FY 2020 ---Implementation of the Inflation Reduction Act (IRA) of 2022 ---Reauthorization of PAHPA Funding for FDA ---H.R.2617: Consolidated Appropriations Act of 2023 ---H.R.7667: The Food and Drug Amendments of 2022 ---H.R.8239: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act ---S.4348: Food and Drug Administration Safety and Landmark Advancements Act of 2022 ---Prescription Drug User Fee Act (PDUFA) VII Priorities Funding for Health Resources and Services Administration (HRSA) ---H.R.2617: Consolidated Appropriations Act of 2023 Funding for National Institutes of Health ---H.R.2617: Consolidated Appropriations Act of 2023 ---H.R.5585: Advanced Research Projects Agency for Health (ARPA-H) Act Funding for the Centers for Disease Control and Prevention Vaccine Programs ---H.R.2617: Consolidated Appropriations Act of 2023 ---Funding for 2022-2023 Influenza Season Preparedness and Response ---Funding for Routine Immunization Infrastructure during Pandemic ---Implementation of the Coronavirus Preparedness and Response Supplemental Appropriations Act for FY 2020 Funding for the HHS Office of Infectious Disease and HIV/AIDS Policy ---H.R.2617: Consolidated Appropriations Act of 2023 Generic Drug Entry ---H.R.2853: Bringing Low-cost Options and Competition while Keeping Incentives for New Generics (BLOCKING) Act of 2021 ---H.R.2883: Stop Stalling Access to Affordable Medications Act ---S.4351/H.R. 6973: Enhanced Access to Affordable Medicines Act ---S.4338/H.R. 7032: Increasing Transparency in Generic Drug Applications Act ---S.4348: Food and Drug Administration Safety and Landmark Advancements Act of 2022 ---Incentives for Generic Entry Medicaid ---H.R.3: Elijah E. Cummings Lower Drug Costs Now Act ---H.R.2139/S.908: Medicare Drug Price Negotiation Act ---H.R.5125: Strengthening Innovation in Medicare and Medicaid Act ---H.R.7389: Medicaid VBPs for Patients (MVP) Act of 2022 ---S.3013: Encouraging Innovation Benefit Design to Lower Costs for Seniors Act of 2019 ---S.4293: Pharmacy Benefit Manager Transparency Act of 2022 ---Alternative Payment Arrangements for Gene Therapies ---Coverage of Accelerated Approval Products ---Drug Benefit Design ---Pricing and Rebates Opioid Crisis ---Non-Opioid Analgesics Orphan Drug Issues ---H.R.5566: Finding Orphan-Disease Remedies with Antifungal Research and Development (FORWARD) Act ---S.4185: Retaining Access and Restoring Exclusivity (RARE) Act ---Implementation of the Inflation Reduction Act (IRA) of 2022 ---Orphan Drug Tax Credit Rare Pediatric Disease Priority Review ---H.R.6888/S.4071: Helping Experts Accelerate Rare Treatments (HEART) Act ---H.R.6972/S.4215: Give Kids a Chance Act of 2022 Reimbursement and Coverage of Innovative Products ---H.R.3: Elijah E. Cummings Lower Drug Costs Now Act ---H.R.19/S.2164: Lower Costs, More Cures Act of 2021 ---H.R.2071: Medicare Prescription Drug Price Negotiation Act of 2021 ---H.R.2139/S.908: Medicare Drug Price Negotiation Act ---H.R.2148/S.909: Prescription Drug Price Relief Act ---H.R.9127: Mandating Exclusive Review of Individual Treatments (MERIT) Act ---H.R.9358: Access to Innovative Treatments Act of 2022 ---S.2327: Seniors Prescription Drug Relief Act ---S.2416: New Opportunities for Value that Extend Lives (NOVEL) Act of 2021 ---Administration Rebate Rule ---CMMI Authority ---Implementation of the Inflation Reduction Act (IRA) of 2022 ---Medicare Part B Physician-Administered Products ---National Coverage Determination ---Patient Cost-Sharing and Smoothing ---Step Therapy Vaccines and Infectious Diseases ---H.R.951/H.R.959/S.345/S.346: Maternal Vaccinations Act of 2021 ---H.R.1978/S.912: Protecting Seniors through Immunizations Act of 2021 ---H.R.2170/S.581: Helping Adults Protect Immunity (HAPI) Act of 2021 ---H.R.2347/S.2691: Strengthening the Vaccines for Children Program Act of 2021 ---H.R.2617: Consolidated Appropriations Act of 2023 ---H.R.3655: Vaccine Injury Compensation Modernization Act of 2021 ---H.R.3932/S.2076: Pioneering Antimicrobial Subscriptions to End Upsurging Resistance (PASTEUR) ---H.R.4127: DISARM Act ---H.R.9127: Mandating Exclusive Review of Individual Treatments (MERIT) Act ---H.R.9358: Access to Innovative Treatments Act of 2022 ---S.4348: Food and Drug Administration Safety and Landmark Advancements Act of 2022 ---S.4509 Vaccine and Coverage Certainty (VACC) Act ---Adult Immunization ---Maternal Immunization ---MCM Manufacturing & Capacity ---MCM R&D Incentives ---Monoclonal Antibody Coverage and Utilization ---National Coverage Determination ---Vaccine and Antimicrobial Resistance Product Development and Incentives ---Vaccine Injury Compensation Program ---Vaccine Safety Vaccine Injury Compensation Program ---H.R.2617: Consolidated Appropriations Act of 2023 ---H.R.3655: Vaccine Injury Compensation Modernization Act of 2021 ---H.R.3656: Vaccine Access Improvement Act of 2021 ---S.3087: Vaccine Access Improvement Act of 2021 ---S.3810: Countermeasure Injury Compensation Fund Amendment Act ---VICP CICP (Discussion Draft)

Client expense: $3,740,000 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), Natl Security Council (NSC), Office of Science & Technology Policy (OSTP), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR), White House Office

Coronavirus (COVID-19) Pandemic ---H.R.2617: Consolidated Appropriations Act of 2023 ---S.3799: Prepare for and Respond to Existing Viruses, Emerging New Threats and (PREVENT) Pandemics Act ---Implementation of the Inflation Reduction Act (IRA) of 2022 Funding for Antimicrobial Resistance (AMR) Programs ---H.R.2617: Consolidated Appropriations Act of 2023 ---H.R.3932/S.2076: Pioneering Antimicrobial Subscriptions to End Upsurging Resistance (PASTEUR) ---H.R.4127: DISARM Act ---H.R.7900: National Defense Authorization Act for FY 2023 ---S.4543: James M. Inhofe National Defense Authorization Act for FY 2023 ---Implementation of the Coronavirus Preparedness and Response Supplemental Appropriations Act for FY 2020 Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement ---H.R.2617: Consolidated Appropriations Act of 2023 ---Funding for Strategic National Stockpile ---Health Defense Operations Funding Designation ---Implementation of the Coronavirus Preparedness and Response Supplemental Appropriations Act for FY 2020 ---Implementation of the Inflation Reduction Act (IRA) of 2022 ---Reauthorization of PAHPA Funding for Biofuels, Biomass Crop Assistance, and Biorefineries ---H.R.2617: Consolidated Appropriations Act of 2023 ---H.R.8239: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act ---Climate Issues & impact on the agriculture, food, and forestry sectors ---Implementation of the Inflation Reduction Act (IRA) of 2022 ---Incentives for Sustainable Aviation Fuels Funding for Biorefineries ---H.R.2617: Consolidated Appropriations Act of 2023 Funding for FDA ---H.R.2617: Consolidated Appropriations Act of 2023 ---H.R.7667: The Food and Drug Amendments of 2022 ---H.R.8239: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act ---S.4348: Food and Drug Administration Safety and Landmark Advancements Act of 2022 ---Prescription Drug User Fee Act (PDUFA) VII Priorities Funding for Health Resources and Services Administration (HRSA) ---H.R.2617: Consolidated Appropriations Act of 2023 Funding for National Institutes of Health ---H.R.2617: Consolidated Appropriations Act of 2023 ---H.R.5585: Advanced Research Projects Agency for Health (ARPA-H) Act Funding for Renewable Chemicals/Bio-based Products ---H.R.2617: Consolidated Appropriations Act of 2023 ---Implementation of the Inflation Reduction Act (IRA) of 2022 Funding for the Centers for Disease Control and Prevention Vaccine Programs ---H.R.2617: Consolidated Appropriations Act of 2023 ---Funding for 2022-2023 Influenza Season Preparedness and Response ---Funding for Routine Immunization Infrastructure during Pandemic ---Implementation of the Coronavirus Preparedness and Response Supplemental Appropriations Act for FY 2020 Funding for the HHS Office of Infectious Disease and HIV/AIDS Policy ---H.R.2617: Consolidated Appropriations Act of 2023 Funding for the USDA ---H.R.2617: Consolidated Appropriations Act of 2023 ---H.R.8239: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act ---Biotechnology and Agriculture Trade Program ---Farm Bill Programs Energy Title IX

Client expense: $3,740,000 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE

Biodefense Research, Development and Procurement Issues (Non-Funding) ---Executive Order on Modernizing Influenza Vaccines ---Implementation of the Coronavirus Preparedness and Response Supplemental Appropriations Act for FY 2020 ---Implementation of Pandemic and All-Hazards Preparedness and Advancing Innovation (PAHPAI) Act of 2019 ---Reauthorization of PAHPA ---White House National Biodefense Strategy Coronavirus (COVID-19) Pandemic ---H.R.2617: Consolidated Appropriations Act of 2023 ---Implementation of the Coronavirus Preparedness and Response Supplemental Appropriations Act for FY 2020 ---R&D Funding for Medical Countermeasures ---Senate HELP Pandemic Preparedness White Paper ---Temporarily Refundable R&D Credit Funding for Antimicrobial Resistance (AMR) Programs ---H.R.2617: Consolidated Appropriations Act of 2023 ---H.R.3932/S.2076: Pioneering Antimicrobial Subscriptions to End Upsurging Resistance (PASTEUR) ---H.R.4127: DISARM Act ---H.R.7900: National Defense Authorization Act for FY 2023 ---S.4543: James M. Inhofe National Defense Authorization Act for FY 2023 ---Implementation of the Coronavirus Preparedness and Response Supplemental Appropriations Act for FY 2020 Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement ---H.R.2617: Consolidated Appropriations Act of 2023 ---Funding for Strategic National Stockpile ---Health Defense Operations Funding Designation ---Implementation of the Coronavirus Preparedness and Response Supplemental Appropriations Act for FY 2020 ---Implementation of the Inflation Reduction Act (IRA) of 2022 ---Reauthorization of PAHPA Funding for National Institutes of Health ---H.R.2617: Consolidated Appropriations Act of 2023 ---H.R.5585: Advanced Research Projects Agency for Health (ARPA-H) Act Funding for the Centers for Disease Control and Prevention Vaccine Programs ---H.R.2617: Consolidated Appropriations Act of 2023 ---Funding for 2022-2023 Influenza Season Preparedness and Response ---Funding for Routine Immunization Infrastructure during Pandemic ---Implementation of the Coronavirus Preparedness and Response Supplemental Appropriations Act for FY 2020

Client expense: $3,740,000 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE, White House Office

Health research; R&D; pandemics PL-117-103 H.R. 5585 / S. 3819 - the Advanced Research Projects Agency-Health (ARPA-H)

Client expense: Not reported · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Psychedelic research related issues S.3479, Building a Sustainable Workforce for Healthy Communities Act, Entirety Monitor Medical Center related issues as follows: H.R.8295/S.4659, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2023 340B Drug Pricing related issues Organ transplant issues Prescription drug pricing, generally H.R.6000, Cures 2.0 Act, generally S.4348, FDASLA Act of 2022, Laboratory developed test issues H.R.5585, ARPA-H Act, Entirety Medicare reimbursement issues, generally Public Law 117-328, Consolidated Appropriations Act, FY2023

Client expense: Not reported · Firm income: $20,000

Government targets: SENATE

Legislation and regulations affecting medical devices, pharmaceuticals, cosmetics and other consumer products; Coronavirus impact and response; social determinants of health; policies impacting Medicare coverage and reimbursement for prescription drugs; MDUFA Reauthorization; PDUFA Reauthorization; H.R.6000, Cures 2.0 Act; H.R.5030/S.2706, DIVERSE Trials Act; H.R.5585, Advanced Research Project Agency-Health Act; S.3799, PREVENT Pandemics Act; H.R.7667, Food and Drug Amendments of 2022; S.4348, FDASLA Act of 2022; H.R.2617, Consolidated Appropriations Act, 2023.

Client expense: Not reported · Firm income: $50,000

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Issues related to the development of therapies for rare diseases and sleep disorders; drug pricing; access to non-controlled medications; PDUFA Reauthorization; H.R.6000, Cures 2.0 Act; H.R.5585, Advanced Research Project Agency-Health Act; H.R.6963, Accelerated Approval Integrity Act of 2022; H.R.2623, Camerons Law; H.R.7667, Food and Drug Amendments of 2022; S.4348, FDASLA Act of 2022; H.R.8641, Orphan Drug COVID-19 Mitigation Act of 2022; H.R.1730/S.670, The Speeding Therapy Access Today (STAT) Act of 2021; H.R.2617, Consolidated Appropriations Act, 2023.

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Policies impacting Medicare coverage and reimbursement for clinical laboratory services; Medicare and Medicaid funding for graduate medical education; Medicaid safety-net issues; Coronavirus impact and response; public health and pandemic preparedness; surprise billing; S.834/H.R.2256, Resident Physician Shortage Reduction Act of 2021; H.R.6000, Cures 2.0 Act; S.2209/H.R.4128, Verifying Accurate Leading-edge IVCT Development Act 6 of 2021; H.R.5585, Advanced Research Project Agency-Health Act; S.3799, PREVENT Pandemics Act; H.R.5721, VIPER Act of 2021; H.R.8188/S.4449, Saving Access to Laboratory Services Act; H.R.7667, Food and Drug Amendments of 2022; S.4348, FDASLA Act of 2022; H.R.2617, Consolidated Appropriations Act, 2023.

Client expense: Not reported · Firm income: $20,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Provide legislative and regulatory advice related to vaccine development, drug pricing, the 340B Drug Pricing Program, PDUFA Reauthorization, and clinical trial diversity; H.R.6000, Cures 2.0 Act; H.R.5585, Advanced Research Project Agency-Health Act; H.R.5030/S.2706, DIVERSE Trials Act; H.R.7667, Food and Drug Amendments of 2022; S.4348, FDASLA Act of 2022; H.R.7559, Prescription Information Modernization Act of 2022; H.R.2873, Affordable Prescriptions for Patients Through Promoting Competition Act of 2021; H.R.2617, Consolidated Appropriations Act, 2023.

Client expense: Not reported · Firm income: $60,000

Government targets: HOUSE OF REPRESENTATIVES

Monitor the following: Cancer Moonshot related issues H.R.8295/S.4659, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2023, Cancer research related issues; and Workforce health issues H.R.5585, ARPA-H Act, Entirety H.R.7667, Food and Drug Amendments of 2022, Entirety S.4348, FDASLA Act of 2022, Diagnostic Test related issues H.R.6000, CURES 2.0, generally Public Law 117-328, Consolidated Appropriations Act, FY2023, Cancer related issues

Client expense: Not reported · Firm income: $30,000

Issues related to the development of therapies for rare diseases and sleep disorders; drug pricing; access to non-controlled medications; PDUFA Reauthorization; H.R.6000, Cures 2.0 Act; H.R.5585, Advanced Research Project Agency-Health Act; H.R.6963, Accelerated Approval Integrity Act of 2022; H.R.2623, Camerons Law; H.R.7667, Food and Drug Amendments of 2022; S.4348, FDASLA Act of 2022; H.R.6833, Making continuing appropriations for fiscal year 2023, and for other purposes (P.L.117-180); H.R.8641, Orphan Drug COVID-19 Mitigation Act of 2022; H.R. 1730/S. 670, The Speeding Therapy Access Today (STAT) Act of 2021;

Client expense: Not reported · Firm income: $20,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Allergy policies (S. 701/H.R. 4114); Diagnostic test reimbursement & regulatory policies (S. 2209/H.R. 4128, S. 2076/H.R. 3932, S.4449/H.R.8188, CY23 CLFS); Precision Medicine (H.R. 6000/H.R. 5989); COVID preparedness products and services; Healthcare supply chain (S. 1693/H.R. 3463, P.L. 117-328); Future pandemic preparedness & response (S. 3799, H.R. 7152/S. 3534, H.R. 3635/S. 1974, P.L. 117-328); User Fees Reauthorization (S. 4328/H.R. 7667); ARPA-H (S. 3819/H.R. 5585); Biotechnology and biomanufacturing.

Client expense: $450,000 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE

Issues related to healthcare research and funding healthcare research; FY2023 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act (H.R.8295, S.4659); H.R.5585, Advanced Research Project Agency-Health Act; S.4348, FDASLA Act of 2022; H.R.2617, Consolidated Appropriations Act, 2023.

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE